Balfanz. J, Rautenberg. P, Ullman. U (1996). ”Molecular Mechanisms of Action of Bacterial Exotoxins”. Zentralblatt für Bakteriologie 284 (2-3): sid. 170–206. doi:10.1016/S0934-8840(96)80095-8.
Spaulding, A. R.; Salgado-Pabon, W.; Kohler, P. L.; Horswill, A. R.; Leung, D. Y. M.; Schlievert, P. M. (2013). ”Staphylococcal and Streptococcal Superantigen Exotoxins”. Clinical Microbiology Reviews 26 (3): sid. 422–447. doi:10.1128/CMR.00104-12.
Kotb, M (1995). ”Bacterial pyrogenic exotoxins as superantigens.”. Clinical Microbiology Reviews 8 (3): sid. 411–426. doi:10.1128/CMR.8.3.411.
Miller, R.; Wiedmann, M. (2016). ”Dynamic Duo—The Salmonella Cytolethal Distending Toxin Combines ADP-Ribosyltransferase and Nuclease Activities in a Novel Form of the Cytolethal Distending Toxin”. Toxins 8 (5): sid. 121. doi:10.3390/toxins8050121.
Moyes, D.; Wilson, D.; Richardson, J.; Mogavero, S.; Tang, S.; Wernecke, J. (2016). ”Candidalysin is a fungal peptide toxin critical for mucosal infection”. Nature 532 (7597): sid. 64–68. doi:10.1038/nature17625.
Wolf, P; Elsässer-Beile, U (2009). ”Pseudomonas exotoxin A: From virulence factor to anti-cancer agent”. International Journal of Medical Microbiology 299 (3): sid. 161–176. doi:10.1016/j.ijmm.2008.08.003. Läst 5 maj 2021.
Pastan, I; Hassan, R; FitzGerald, D; Kreitman, R (2007). ”Immunotoxin Treatment of Cancer*”. Annual Review of Medicine 58 (1): sid. 221–237. doi:10.1146/annurev.med.58.070605.115320.